RecruitingNCT06325267

Clinical Characteristics of Primary Liver Cancer

A Single Center, Retrospective Clinical Study on the Clinical Characteristics of Primary Liver Cancer

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Enrollment

1,000 participants

Start Date

Jan 1, 2010

Study Type

OBSERVATIONAL

Conditions

Primary Liver Cancer

Summary

Primary liver cancer (PLC) is the sixth most common malignancy in the world and the third most common cause of malignancy death. In 2020, there were about 905,677 new cases of PLC worldwide, and 830,180 deaths. Despite the availability of a variety of treatments for PLC, the 5-year net survival rate is still only 5% to 30%. How to effectively reduce the disease burden of PLC is a major public health problem that needs to be solved worldwide. The clinical characteristics and prognosis of PLC caused by different pathogenic factors are different. Therefore, it is of great significance to fully identify the risk factors of PLC, be familiar with the clinical characteristics and prognosis of disease development, and understand the relevant monitoring and follow-up strategies for the prevention and treatment of PLC.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects information about patients newly diagnosed with primary liver cancer to better understand its clinical features — such as how it presents, how it progresses, and what treatments are used. The goal is to build a clearer picture of liver cancer patterns to improve future care. **You may be eligible if...** - You are 18 years or older - You have been newly diagnosed with primary liver cancer, confirmed by CT scan, MRI, or biopsy **You may NOT be eligible if...** - You have a different type of cancer (not primary liver cancer) - You have serious conditions like severe heart or lung disease, major kidney problems, active serious infections, or a history of stroke - You have had a liver or other organ transplant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.